KEMP & COMPANY
|
|
BOM : 506530     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
Jun 30,2025 |
Price(EOD): ₹ 1,363.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Trading |
MCap: ₹ 149.99 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
KEMP & COMPANY | 5.8% | -5.9% | 38.6% |
ADANI ENTERPRISES | -0.4% | 0.8% | -17% |
REDINGTON | -3.3% | 0.1% | 43.3% |
MMTC | -2.4% | -4.7% | -18.5% |
HONASA CONSUMER | -0.7% | -5.6% | -33.7% |
LLOYDS ENTERPRISES | 1.1% | 24.6% | 141.3% |
ENTERO HEALTHCARE SOLUTIONS | 5.6% | 6.2% | 15% |
OPTIEMUS INFRACOM | -2.4% | 0.4% | 49.2% |
POLO QUEEN INDUSTRIAL & FINTECH | -2.8% | -5.9% | 27.7% |
FUNDAMENTAL ANALYSIS OF KEMP & COMPANY
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF KEMP & COMPANY
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
-133.9
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -1.10 Cr
[Latest Qtr - Mar2025 - Standalone Results ] 1.14
P/B Calculated based on Book Value of Rs 129.54 Cr
[Latest Year - Mar2025 - Standalone Results ] 50.62
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Mar2025 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
NA 154% 149% |
SHARE PRICE MOMENTUM OF KEMP & COMPANY
KEMP & COMPANY vs SENSEX
DEBT OF KEMP & COMPANY
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0 0 0 - |
- - - - |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF KEMP & COMPANY
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2025 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF KEMP & COMPANY
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
1.33% 14.47% 1.4% -72.56% |
2.56% 43.97% -184.13% -268.64% |
QtrlyTrend |
2 | |
Latest Qtr: Mar2025 | ||
Quarterly Result Analysis → |
KEMP & COMPANY related INDICES
You may also like the below Video Courses
FAQ about KEMP & COMPANY
Is KEMP & COMPANY good for long term investment?
As on Jun 30,2025, the Fundamentals of KEMP & COMPANY look Poor and hence it may not be good for long term investment ! See Financial Performance of KEMP & COMPANY . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is KEMP & COMPANY UnderValued or OverValued?
As on Jun 30,2025, KEMP & COMPANY is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of KEMP & COMPANY ?
As on Jun 30,2025, the Intrinsic Value of KEMP & COMPANY is Rs. 541.90 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -569.88
Fair Value [Median EV / Sales Model] : Rs. 536.75
Fair Value [Median Price / Sales Model] : Rs. 547.05
Estimated Median Fair Value of KEMP & COMPANY : Rs. 541.90
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is KEMP & COMPANY trading at a Premium or Discount?
As on Jun 30,2025, KEMP & COMPANY is trading at a Premium of 152% based on the estimates of Median Intrinsic Value!ADANI ENTERPRISES LTD vs REDINGTON LTD vs MMTC LTD
HONASA CONSUMER LTD vs LLOYDS ENTERPRISES LTD vs ENTERO HEALTHCARE SOLUTIONS LTD